肺炎球菌结合疫苗对早产儿与足月儿社区获得性肺泡性肺炎发病率的影响
以色列一项前瞻性、主动、基于人群的监测研究,比较肺炎球菌结合疫苗(PCV)实施前后早产儿与足月儿社区获得性肺泡性肺炎(CAAP)发病率变化,结果显示PCV实施后CAAP就诊总体下降44%,早产儿与足月儿CAAP发病率差距缩小。
要点
- PCV实施后CAAP总就诊率下降44%(95%CI 36-51)。
- 早产儿与足月儿CAAP下降趋势相似,组间发病率差距缩小。
- 住院患儿CAAP下降幅度低于非住院患儿。
核心结论
- PCV实施后早产儿CAAP下降趋势与足月儿相似,早产儿与足月儿CAAP发病率差距缩小。
- 该相似性源于直接PCV保护、间接(群体)保护或两者兼有尚不清楚。
研究设计与样本
- 按胎龄分为早期早产儿(29-32周)、晚期早产儿(33-36周)和足月儿(>36周),比较PCV实施前后CAAP发病率。
- CAAP为影像学证实的社区获得性肺泡性肺炎,患儿就诊于唯一区域医疗中心。
主要发现
- PCV实施后CAAP总就诊率下降44%(95%CI 36-51);早期早产儿下降60%、晚期早产儿下降21%、足月儿下降45%(早期早产儿和足月儿有统计学意义)。
- 门诊CAAP下降率分别为早期早产儿79%、晚期早产儿40%、足月儿65%(足月儿有统计学意义)。
- 住院CAAP下降率分别为早期早产儿56%、晚期早产儿16%、足月儿33%(早期早产儿和足月儿有统计学意义)。
- PCV实施后三个组的平均年发病率变得相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preterm-born children are prone to respiratory infections and complications during infancy and early childhood. In Israel, pneumococcal conjugated vaccines (PCVs) were introduced in 2009-2010, with high vaccination coverage. We assessed the impact of PCV implementation on community-acquired alveolar pneumonia (CAAP) in children < 2 years old born prematurely, in comparison with term born infants. METHODS: We conducted a prospective, active, population-based surveillance of children < 2 years old with radiologically-proven CAAP, visiting the only regional medical center. CAAP incidence in the pre-PCV and post-PCV eras were compared in early premature (29-32 weeks gestational age [WGA]), late premature (33-36 WGA) and term-born infants (>36 WGA). RESULTS: Of 214,947 births during the study period, 6'791 CAAP episodes were diagnosed; 211, 653 and 5,806 were in early premature, late premature and term infants, respectively. After PCV implementation, overall CAAP visits were reduced by 44% (95% CI 36-51): 60%, 21% and 45% among those born early preterm, late preterm and at term, respectively (statistically significant for children born early preterm and at term). For outpatients, the respective rate reductions were 79%, 40% and 65% (statistically significant for the children born at term). Importantly, the mean annual rates in the post-PCV period became similar in all 3 groups. The rate reductions among the hospitalized children were lower those that among the non-hospitalized children, with reductions of 56%, 16% and 33% for the three groups, respectively (statistically significant for early preterm and at term children). CONCLUSIONS: CAAP reduction trends after PCV implementation for preterm-born infants were similar to those for term-born infants. Whether this was because of similar direct PCV- protection, because of indirect (herd) protection or both, is unclear. Post-PCV implementation, the gaps in CAAP rates between infants born prematurely and at term were reduced.
引用
- Faingelernt Y, Dagan R, Givon-Lavi N, et al. The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants. Vaccine. 2021. PMID: 34973848. doi:10.1016/j.vaccine.2021.12.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。